Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown

Apr.08
According to Reuters, the U.S. vaping market has recently seen an increase in products marketed as “Made in America” amid the Trump administration’s stronger enforcement against unauthorized vape brands and increased trade tariff pressure on Chinese goods. Since October 2025, at least eight new vape brands highlighting American credentials have entered the U.S. market, and none of them has authorization for sale. Brands mentioned by Reuters include Maxus Star and OneTank.

Key Takeaways

  • Since last October, at least eight new vape brands among unauthorized products in the U.S. market have emphasized American identity in their marketing, and none of them has authorization for sale in the United States.
  • Some vape brands are using marketing elements such as stars and stripes and “built in the USA” labels.
  • Trademark documents and business filings show that some of the eight brands are controlled by U.S. firms, while at least two are owned by companies from mainland China or Hong Kong, China.
  • British American Tobacco estimated the U.S. vape market was worth about USD 12.00 billion in 2024 and said unauthorized products account for about 70.00% of U.S. vape sales.

2Firsts, April 8, 2026 

According to Reuters’ April 7 report titled Vape makers turn to ‘Made in America’ credentials amid Trump’s tariffs, crackdown,” the U.S. vaping market, long dominated by Chinese imports, is seeing an increase in products marketed as “Made in America.” Some analysts and industry executives said this reflects a shift in marketing strategy as the Trump administration intensifies enforcement against unauthorized brands.

At least eight new brands have emphasized “Made in America” credentials since last October

Reuters said the United States is the world’s largest vape market and a key target for major tobacco companies such as British American Tobacco, which estimated the market was worth around USD 12.00 billion in 2024.

The report said most vapes globally are produced in China and imported into the United States, often without formal regulatory authorization. According to Reuters’ analysis, at least eight new vape brands have appeared on U.S. shelves since last October and have highlighted their American credentials through brand presentation.

Trademark records and business filings show that none of these eight brands has authorization for sale in the United States. Some are controlled by U.S. firms, while at least two are owned by companies from mainland China or Hong Kong, China.

Analysts say the strategy may be aimed at reducing customs scrutiny

Barclays analyst Pallav Mittal said the vape companies appear to be betting that emphasizing American credentials will make their brands less likely to attract the attention of customs officials looking for unauthorized Chinese vapes at the U.S. border.

He said this could mean the U.S. crackdown on the large illegal vape market may have an even more gradual effect than major tobacco companies had hoped. If illegal players have found another way to remain in the U.S. market, then the shift from illegal to legal products could slow down.

The U.S. Food and Drug Administration declined to comment on whether there has been a shift toward U.S. production of vapes, but said it is illegal to sell unauthorized vapes regardless of where they are made.

Several brands promote “Made in America,” but production locations were not confirmed

Reuters cited Maxus Star as an example. The brand’s website uses the slogan “Vape American” and shows devices carrying stars and stripes as well as a “built in the USA” label. Reuters said it could not verify where the device is actually manufactured.

Trademark documents show that the MAXUS brand in the United States is owned by Hong Kong-based Rivermountain (H.K.) Tech, which also holds trademarks in China for several sub-brands of Chinese vape maker Freemax. Maxus Star, Freemax, and Rivermountain did not respond to requests for comment.

Another new label, OneTank, displays a U.S. flag and the phrase “made in USA” on its packaging.

Local business filings and U.S. trademark records show that the brand is controlled by a representative of Shenzhen Onevape Technology. Reuters also could not establish whether OneTank has any manufacturing site in the United States.

Some companies may be testing U.S. filling operations to reduce tariff and supply chain pressure

Steve Xu, an adjunct assistant professor at the University of Waterloo who follows the industry, said some manufacturers may be trialing U.S. production or increasing their use of U.S.-made vape liquids to help reduce tariff costs.

Reuters also said that U.S.-based vape company Charlie’s Holdings Inc. opened its first U.S. factory in December to fill one of its disposable vape brands with e-liquid. The company said the move was linked to supply chain disruptions associated with importing finished devices and to consumer preference for “Made in America” brands.

However, its annual report also states that its disposable vapes are still produced by a Chinese manufacturing partner.

BAT says unauthorized vapes account for 70.00% of U.S. sales

British American Tobacco said unauthorized vapes account for about 70.00% of U.S. vape sales, which has also reduced the market share of its own devices. Reuters noted that the FDA has authorized only 41 vape products for sale in the United States.

A vape industry consultant who works with Chinese firms said the increase in “Made in America” vape marketing reflects the fact that U.S. consumers are repeatedly hearing from the Trump administration that goods made in China are bad. Some tobacco companies also said, without providing evidence, that the trend suggests Chinese rivals are shifting tactics.

However, Chinese trade data show no decline in vape exports from China to the United States in 2025, with shipments still worth more than USD 4.00 billion.

British American Tobacco CEO Tadeu Marroco said this approach was intended to “get around” state and federal regulations. He added that as the administration increases enforcement, the companies “get more creative.”

Image Source: Reuters


Further reading:

2FIRSTS | Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
2FIRSTS | Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
www.2firsts.com

BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
British American Tobacco (BAT) plans to cut about 5,500 jobs globally and shift around 3,500 roles to strategic partners by the end of 2026, affecting about 9,000 roles in total, as the company seeks to simplify operations, strengthen technology capabilities and deliver £600 million in annual savings by 2028.
BAT
Jun.29
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
Indonesia’s BNN Pushes Total Vape Ban as Health Ministry Tightens Tobacco Packaging Rules, Putting $40 Billion Industry at Risk
Indonesia’s BNN Pushes Total Vape Ban as Health Ministry Tightens Tobacco Packaging Rules, Putting $40 Billion Industry at Risk
Indonesia is entering a new phase of debate over vape and tobacco regulation. The National Narcotics Agency (BNN) has proposed a total vape ban, with some lawmakers supporting stronger restrictions. At the same time, the Health Ministry is advancing tobacco and nicotine regulations under Government Regulation No. 28/2024, including measures such as plain packaging and product controls. Tobacco and vape industries have warned that tighter rules could affect a sector worth around $40 billion, supporting about 6 million jobs and contributing significant tax revenue.
Jul.27
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
French Vape Distributor Kumulus Vape Yields About 3% as Earnings Growth Stalls
French Vape Distributor Kumulus Vape Yields About 3% as Earnings Growth Stalls
Listed French vape distributor Kumulus Vape will trade ex-dividend on June 26, 2026, and pay an annual dividend of €0.10 per share on June 30, with Simply Wall St saying the payout is covered by profit and free cash flow, while weak earnings growth remains a concern.
Industry InsightMarketNews
Jun.24